BWX Technologies (BWXT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
2024 delivered record annual revenue of $2.7B, adjusted EBITDA of $499M, adjusted EPS of $3.33, and free cash flow of $255M, all meeting or exceeding guidance.
Q4 2024 revenue was $746M, up 3% year-over-year, led by strong Commercial Operations, while Government Operations saw a slight decline.
Backlog ended at $4.84B, up 21% year-over-year, driven by large contract awards in both operating segments.
Strategic investments and acquisitions, including the completed AOT acquisition and pending Kinectrics deal, are expanding capabilities and market reach.
Strong demand in national security, clean energy, and medical markets is fueling growth and bookings.
Financial highlights
Q4 revenue was $746M, up 3% organically; full-year free cash flow reached $255M, up 20% year-over-year.
Adjusted EBITDA for Q4 was $130M (down 12% YoY); full-year adjusted EBITDA grew 6% to $499M.
Adjusted EPS for Q4 was $0.92 (vs. $1.01 YoY); full-year adjusted EPS up 10% to $3.33.
2024 net income was $282.3M, up 15% year-over-year.
Adjusted effective tax rate for 2024 was 21.7%, below guidance, with a $6M Q4 benefit from tax planning.
Outlook and guidance
2025 revenue expected at ~$3B, with mid-single-digit growth in government operations and mid-teens to nearly 50% growth in commercial operations, including Kinectrics.
Adjusted EBITDA guidance for 2025 is $550M–$570M; non-GAAP EPS guidance is $3.40–$3.55.
Free cash flow expected at $265M–$285M in 2025, with CapEx at 5–6% of sales.
Kinectrics acquisition expected to close mid-2025, contributing ~$150M revenue and ~$20M EBITDA in 2025.
Tax rate expected to rise 20–40bps in 2025 due to geographic mix shift.
Latest events from BWX Technologies
- Q2 2026 revenue up 18% to $901.6M, Commercial Ops up 72%, and guidance raised for the year.BWXT
Q2 20263 Aug 2026 - Q3 2024 revenue up 14% to $672M, EPS guidance raised, and $98M+ acquisition announced.BWXT
Q3 20248 Jul 2026 - Q1 2026 saw 26% revenue growth, higher earnings, record backlog, and raised guidance.BWXT
Q1 20265 May 2026 - Record 2025 growth and backlog set stage for robust 2026 gains across all key metrics.BWXT
Q4 202510 Apr 2026 - 2026 outlook projects high-teens revenue growth and double-digit free cash flow, fueled by nuclear demand.BWXT
Investor presentation18 Mar 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor on April 30, 2026.BWXT
Proxy Filing18 Mar 2026 - Q2 2024 delivered double-digit growth and a higher EPS outlook amid strong industry demand.BWXT
Q2 20242 Feb 2026 - $525M acquisition expands nuclear and isotope services, boosting global reach and workforce.BWXT
M&A Announcement10 Jan 2026 - Q1 2025 revenue up 13%, net income $75.5M, backlog $4.88B, 2025 outlook reaffirmed.BWXT
Q1 202525 Dec 2025